PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Sciences, University of Milan, Milan 20146, Italy.\', \'INGM - Istituto Nazionale Genetica Molecolare \'Romeo ed Enrica Invernizzi\', Milan 20122, Italy.\', \'INGM - Istituto Nazionale Genetica Molecolare \'Romeo ed Enrica Invernizzi\', Milan 20122, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.\', \'D3 Validation Research Line, Istituto Italiano di Tecnologia, Genoa 16163, Italy.\', \'Institute of Life Sciences, Scuola Superiore Sant\'Anna, Pisa 56127, Italy.\', \'D3 Validation Research Line, Istituto Italiano di Tecnologia, Genoa 16163, Italy. Electronic address: paolo.ciana@unimi.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1043-6618(21)00566-110.1016/j.phrs.2021.105982
?:hasPublicationType
?:journal
  • Pharmacological research
is ?:pmid of
?:pmid
?:pmid
  • 34798263
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all